• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DLX3 和 CD271 能否保护人类角质细胞免受鳞状肿瘤的发生?

Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?

机构信息

Laboratory of Cutaneous Biology, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, 41100 Modena, Italy.

Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Int J Mol Sci. 2019 Jul 19;20(14):3541. doi: 10.3390/ijms20143541.

DOI:10.3390/ijms20143541
PMID:31331058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6678400/
Abstract

Well-regulated epidermal homeostasis depends on the function of different classes of factors, such as transcription regulators and receptors. Alterations in this homeostatic balance may lead to the development of cutaneous squamous tumorigenesis. The homeobox transcription factor DLX3 is determinant for a p53-dependent regulation of epidermal differentiation and modulates skin carcinogenesis. The maintenance of skin homeostasis also involves the action of neurotrophins (NTs) and their receptors, Trk and CD271. While Trk receptor overexpression is a hallmark of cancer, there are conflicting data on CD271 expression and function in cutaneous SCC (cSCC). Previous studies have reported NT receptors expression in head and neck SSC (HNSCC). We show that CD271 is expressed at low levels in primary cSCC cells and the number of CD271+ cells correlates with cell cohesion in SCC spheroids. In normal epidermis, CD271 is expressed in proliferative progenitor cells and DLX3 in terminally differentiated keratinocytes. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) increase DLX3 expression. In the absence of a functional BDNF receptor TrkB in keratinocytes, we hypothesize that the BDNF-dependent DLX3 response could be mediated via CD271. Altogether, our results support a putative CD271-DLX3 connection in keratinocytes, which might be crucial to preventing squamous skin cancer.

摘要

正常的表皮稳态依赖于不同类别的因素的功能,例如转录调节剂和受体。这种内稳态平衡的改变可能导致皮肤鳞状细胞肿瘤发生。同源盒转录因子 DLX3 是 p53 依赖性表皮分化调节的决定因素,并调节皮肤癌发生。皮肤稳态的维持还涉及神经营养因子(NTs)及其受体 Trk 和 CD271 的作用。虽然 Trk 受体过表达是癌症的标志,但 CD271 在皮肤鳞状细胞癌(cSCC)中的表达和功能存在矛盾的数据。先前的研究报道了头颈部鳞状细胞癌(HNSCC)中 NT 受体的表达。我们表明,CD271 在原发性 cSCC 细胞中低表达,并且 CD271+细胞的数量与 SCC 球体中的细胞黏附力相关。在正常表皮中,CD271 在增殖性祖细胞中表达,DLX3 在终末分化的角质形成细胞中表达。脑源性神经营养因子(BDNF)和神经营养因子 3(NT3)增加 DLX3 的表达。在角质形成细胞中缺乏功能性 BDNF 受体 TrkB 的情况下,我们假设 BDNF 依赖性 DLX3 反应可以通过 CD271 介导。总之,我们的结果支持角质形成细胞中存在假定的 CD271-DLX3 连接,这对于预防鳞状皮肤癌可能至关重要。

相似文献

1
Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?DLX3 和 CD271 能否保护人类角质细胞免受鳞状肿瘤的发生?
Int J Mol Sci. 2019 Jul 19;20(14):3541. doi: 10.3390/ijms20143541.
2
A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation.一种新型的DLX3-PKC整合信号网络驱动角质形成细胞分化。
Cell Death Differ. 2017 Apr;24(4):717-730. doi: 10.1038/cdd.2017.5. Epub 2017 Feb 10.
3
CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes.CD271 激活可预防皮肤鳞状细胞癌的低危向高危进展,并改善治疗效果。
J Exp Clin Cancer Res. 2023 Jul 13;42(1):167. doi: 10.1186/s13046-023-02737-7.
4
The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.同源异型蛋白DLX3和肿瘤抑制因子p53共同调节细胞周期进程和鳞状肿瘤生长。
Oncogene. 2016 Jun 16;35(24):3114-24. doi: 10.1038/onc.2015.380. Epub 2015 Nov 2.
5
Relevance of Neurotrophin Receptors CD271 and TrkC for Prognosis, Migration, and Proliferation in Head and Neck Squamous Cell Carcinoma.神经生长因子受体 CD271 和 TrkC 对头颈鳞状细胞癌的预后、迁移和增殖的相关性。
Cells. 2019 Sep 28;8(10):1167. doi: 10.3390/cells8101167.
6
Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.DLX3 肿瘤抑制功能丧失通过 EGFR-ERBB2 通路促进 SCC 的进展。
Oncogene. 2021 May;40(21):3680-3694. doi: 10.1038/s41388-021-01802-9. Epub 2021 May 4.
7
CD271 defines a stem cell-like population in hypopharyngeal cancer.CD271 定义了下咽癌中的干细胞样群体。
PLoS One. 2013 Apr 23;8(4):e62002. doi: 10.1371/journal.pone.0062002. Print 2013.
8
CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.CD271 通过上调 Slug 赋予头颈部鳞状细胞癌侵袭性和转移性表型。
Clin Cancer Res. 2018 Feb 1;24(3):674-683. doi: 10.1158/1078-0432.CCR-17-0866. Epub 2017 Dec 5.
9
Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity.CD271的表观遗传调控,CD271是一种与化疗耐药性和转移能力相关的潜在癌症干细胞标志物。
Oncol Rep. 2015 Jan;33(1):425-32. doi: 10.3892/or.2014.3569. Epub 2014 Oct 24.
10
CD271 mediates stem cells to early progeny transition in human epidermis.CD271 介导人类表皮中的干细胞向早期祖细胞的转化。
J Invest Dermatol. 2015 Mar;135(3):786-795. doi: 10.1038/jid.2014.454. Epub 2014 Oct 20.

引用本文的文献

1
The Role of the Neurotrophin Network in Skin Squamous Cell Cancer and the Novel Use of the Zebrafish System.神经营养因子网络在皮肤鳞状细胞癌中的作用及斑马鱼系统的新应用。
JID Innov. 2024 Jun 5;4(5):100295. doi: 10.1016/j.xjidi.2024.100295. eCollection 2024 Sep.
2
CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes.CD271 激活可预防皮肤鳞状细胞癌的低危向高危进展,并改善治疗效果。
J Exp Clin Cancer Res. 2023 Jul 13;42(1):167. doi: 10.1186/s13046-023-02737-7.
3
Investigating Cutaneous Squamous Cell Carcinoma and : Novel 3D Tools and Animal Models.

本文引用的文献

1
Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.皮肤鳞状细胞癌:发病率、危险因素、诊断和分期。
J Am Acad Dermatol. 2018 Feb;78(2):237-247. doi: 10.1016/j.jaad.2017.08.059.
2
DLX3-Dependent STAT3 Signaling in Keratinocytes Regulates Skin Immune Homeostasis.角质细胞中依赖 DLX3 的 STAT3 信号传导调节皮肤免疫稳态。
J Invest Dermatol. 2018 May;138(5):1052-1061. doi: 10.1016/j.jid.2017.11.033. Epub 2017 Dec 12.
3
Targeting TRK family proteins in cancer.在癌症中靶向 TRK 家族蛋白。
皮肤鳞状细胞癌的研究及:新型3D工具和动物模型。 (原标题中“and”后似有缺失内容)
Front Med (Lausanne). 2022 May 9;9:875517. doi: 10.3389/fmed.2022.875517. eCollection 2022.
4
Wnt/CTNNB1 Signal Transduction Pathway Inhibits the Expression of ZFP36 in Squamous Cell Carcinoma, by Inducing Transcriptional Repressors SNAI1, SLUG and TWIST.Wnt/CTNNB1 信号转导通路通过诱导转录抑制因子 SNAI1、SLUG 和 TWIST 抑制鳞状细胞癌中 ZFP36 的表达。
Int J Mol Sci. 2020 Aug 8;21(16):5692. doi: 10.3390/ijms21165692.
5
Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy.分子方法治疗皮肤鳞状细胞癌:从通路到治疗。
Int J Mol Sci. 2020 Feb 12;21(4):1211. doi: 10.3390/ijms21041211.
Pharmacol Ther. 2017 May;173:58-66. doi: 10.1016/j.pharmthera.2017.02.006. Epub 2017 Feb 4.
4
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.CD271下调促进黑色素瘤在三维模型和斑马鱼中的进展与侵袭。
J Invest Dermatol. 2016 Oct;136(10):2049-2058. doi: 10.1016/j.jid.2016.05.116. Epub 2016 Jun 18.
5
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.头颈部鳞状细胞癌中的TP53突变及其对疾病进展和治疗反应的影响。
J Cell Biochem. 2016 Dec;117(12):2682-2692. doi: 10.1002/jcb.25592. Epub 2016 Jun 3.
6
Oncogenic Ras: A double-edged sword for human epidermal stem and transient amplifying cells.致癌性Ras:人类表皮干细胞和短暂扩增细胞的双刃剑。
Small GTPases. 2016 Jul 2;7(3):147-55. doi: 10.1080/21541248.2016.1182242. Epub 2016 Apr 25.
7
Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo.生存素调节鳞状细胞癌来源的干细胞样细胞的增殖、活力及体内肿瘤形成。
Int J Mol Sci. 2016 Jan 12;17(1):89. doi: 10.3390/ijms17010089.
8
The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.同源异型蛋白DLX3和肿瘤抑制因子p53共同调节细胞周期进程和鳞状肿瘤生长。
Oncogene. 2016 Jun 16;35(24):3114-24. doi: 10.1038/onc.2015.380. Epub 2015 Nov 2.
9
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.恩曲替尼:一种强效的新型TRK、ROS1和ALK抑制剂。
Expert Opin Investig Drugs. 2015;24(11):1493-500. doi: 10.1517/13543784.2015.1096344. Epub 2015 Oct 12.
10
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101.一名软组织肉瘤患者中存在致癌性NTRK融合,对原肌球蛋白相关激酶抑制剂LOXO-101有反应。
Cancer Discov. 2015 Oct;5(10):1049-57. doi: 10.1158/2159-8290.CD-15-0443. Epub 2015 Jul 27.